Role of endogenous endothelin in chronic heart failure: Effect of long- term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

Circulation

Volumn 96, Issue 6, 1997, Pages 1976-1982

  Mulder, Paul ^b   Richard, Vincent ^b   Derumeaux, Geneviève ^b   Hogie, Manuela ^b   Henry, Jean Paul ^b   Lallemand, Françoise ^b   Compagnon, Patricia ^b   Macé, Bertrand ^b   Comoy, Etienne ^b   Letac, Brice ^b   Thuillez, Christian ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b NONE

Author keywords

Echocardiograph; Endothelin; Heart failure; Survival

Indexed keywords

BOSENTAN; CATECHOLAMINE; COLLAGEN; CYCLIC GMP; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DRUG EFFECT; HEART AFTERLOAD; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEART PRELOAD; HEART RATE; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRESSOR RESPONSE; PRESSURE VOLUME CURVE; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 0030817074     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.6.1976     Document Type: Article

References (39)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Cavero PG, Miller WL, Heublein DM, Margulies KB, Burnett JC Jr. Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 1990;259:F312-F317.
3. Margulies KB, Hildebrand FL Jr, Lerman A, Perrella MA, Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation. 1990;82:2226-2230.
4. Underwood RD, Aarhus LL, Heublein DM, Burnett JC Jr. Endothelin in thoracic inferior vena cava constriction model of heart failure. Am J Physiol. 1992;263:H951-H955.
5. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20:849-853.
6. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
7. Stewart DJ, Cernacek P, Costello KB, Rouleau JL. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 1992;85:510-517.
8. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr. Endothelin in human congestive heart failure. Circulation. 1994;89: 1580-1586.
9. Cannan CR, Burnett JC Jr, Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental chronic heart failure. Circulation. 1996;93:646-651.
10. Noll G, Tschudi M, Novosel D, Lüscher TF. Activation of the L-arginine/nitric oxide pathway and endothelin-1 in experimental heart failure. J Cardiovasc Pharmacol. 1994;23:916-921.
11. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction. Circulation. 1994;89: 1573-1579.
12. Teerlink JR, Löffler BM, Hess P, Maire JP, Clozel M, Clozel JP. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation. 1994;90: 2510-2518.
13. Sakai S, Miyauchi T, Sakurai T, Kasuya Y, Ihara M, Yamaguchi I, Goto K, Sugishita Y. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation. 1996;93:1214-1222.
14. Shimoyama H, Sabbah HN, Borzak S, Tanimura M, Shevlyagin S, Scicli G, Goldstein S. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure. Circulation. 1996;94:779-785.
15. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995;346: 732-736.
16. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long term survival in heart failure. Nature. 1996;384:353-355.
17. Cohn JN. Is there a role for endothelin in the natural history of heart failure? Circulation. 1996;94:604-606.
18. Clozel M, Breu V, Gray GA, Kalina B, Löffler B, Burri K, Cassal J, Hirth G, Müller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270: 228-235.
19. Mulder P, Richard V, Compagnon P, Henry JP, Lallemand F, Clozel JP, Koen R, Macé B, Thuillez C. Increased survival after chronic treatment with mibefradil, a selective T channels calcium antagonist, in heart failure. J Am Coll Cardiol. 1997;29:416-421.
20. Löffler B, Maire JP. Radioimmunological determination of endothelin peptides in human plasma: a methodological approach. Endothelium. 1994;1:273-286.
21. Fletcher PJ, Pfeffer MA, Pfeffer JM, Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction: effects on systolic function. Circ Res. 1981;49:618-626.
22. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation. 1994;89:345-354.
23. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58: 1072-1083.
24. Mulder P, Elfertak L, Richard V, Compagnon P, Devaux B, Henry JP, Scalbert E, Desché P, Macé B, Thuillez C. Peripheral artery structure and endothelial function in heart failure: effect of ACE inhibition. Am J Physiol. 1996;271:H469-H477.
25. Mulder P, Devaux B, Richard V, Henry JP, Wimart MC, Thibout E, Macé B, Thuillez C. Early vs delayed angiotensin converting enzyme inhibition in experimental chronic heart failure: effects on survival, hemodynamics and cardiovascular remodeling. Circulation. 1997;95:1314-1319.
26. Weber KT, Janicki JS, Schroff SG, Pick R, Chen RM, Bashey RI. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988;62:757-765.
27. Mantel N. Chi-square tests with one degree of freedom: extension of the Mantel-Haenszel procedure. J Am Stat Assoc. 1963;58: 690-700.
28. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circ Res. 1985;72:406-412.
29. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Sparado J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
30. Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pflugers Arch. 1988;413:108-110.
31. A receptors in guinea pig atria. Circ Res. 1995;76:284-292.
32. Boarder MR, Marriott DB. Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells. Biochem Pharmacol. 1991;41:521-526.
33. Lüscher TF, Yang Z, Von Segesser L, Stulz P, Boulanger C, Siebenmann R, Turina M, Buhler F. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res. 1990;66:1088-1094.
34. Ishikawa T, Li L, Shinmi O, Kimura S, Yanagisawa M, Goto K, Masaki T. Characteristics of binding of endothelin-1 and endothelin-3 to rat hearts: developmental changes in mechanical responses and receptor subtypes. Circ Res. 1991;69:918-926.
35. B receptors in rats. Biochem Biophys Res Commun. 1994;199:1461-1465.
36. B receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem Biophys Res Commun. 1992;186:867-873.
37. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 1994;89:1203-1208.
38. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelin on collagen turnover in cardiac fibroblasts. Cardiovasc Res. 1993;27:2130-2134.
39. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 1996;95:2131-2137.